{
    "medicine_id": "9909b131a56ed421c54d93013c25eec9191b8421",
    "platform_id": "DB09267",
    "metadata": {
        "name": "Osseor 2 g Granule",
        "composition": "2 g Strontium ranelate",
        "clinical_particulars": {
            "therapeutic_indications": "Strontium ranelate is therapeutically indicated for the treatment of severe osteoperosis in a postmenopasual women and b adult men who are at high risk of fractures for whom treatment with other medical products approved for the treatment of osteoperosis is not possible due to for example contraindications or intolerance L1127 In postmenopausal women strontium ranelate can also reduce the risk of vertebral and hip fractures L1127",
            "contraindications": {
                "disease": "Strontium ranelate has been withdrawn worldwide owing to an increased adverse cardiac effects profile along with increased risk of venous thromboembolism VTE and various life threatening allergic reactions In pooled randomised placebo controlled studies of post menopausal osteoporotic patients a significant increase in myocardial infarction has been observed in patients treated with strontium ranelate compared to placebo L1127 Patients with significant risk factors for cardiovascular events ie hypertension hyperlipidemia diabetes mellitus smoking would be susceptible to an even higher risk of cardiac ishaemic events like myocardial infarction L1127 In phase III placebo controlled studies strontium ranelate treatment was associated with an increase in the annual incidence of venous thromboembolism VTE including pulmonary embolism This places substantial risk on patients at risk of VTE and elderly over 80 years patients at risk of VTE who may be more commonly associated with illnesses or conditions leading to immobilisation L1127 Life threatening cutaneous reactions like Stevens Johnson syndrome SJS toxic epidermal necrolysis TEN and drug rash with eosinophilia and systemic symptoms DRESS have been reported with the use of strontium ranelate In particular a higher incidence of such reactions has been reported in patients of Asian origin L1127 In a pooled analysis of randomised placebo controlled studies in post menopausal osteoporotic patients the most common adverse reactions consisted of nausea and diarrhea L1127 Nevertheless good tolerance was shown in a clinical study investigating the repeated administration of 4 g strontium ranelate per day over 25 days in healthy postmenopausal women FDA Label Single administration of doses up to 11 g in healthy young male volunteers did not cause any particular symptoms FDA Label In patients with mild to moderate renal impairment 30 70 ml min creatine clearance strontium clearance decreases as creatinine clearance decreases approximately 30 decrease over the creatinine clearance range 30 to 70 ml min and thereby induces an increase in strontium plasma levels However no dosage adjustment is required for patients with miod to moderate renal impairment although no pharmacokinetic data exists for patients with severe renal impairment associated with creatinine clearance below 30 ml min L1127 There are no data from the use of strontium ranelate in pregnant women L1127 Physico chemical data suggests strontium ranelate can be excreted into human milk Strontium ranelate should not be used during breastfeeding L1127 No effects were observed on male and female fertility in animal studies L1127",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "In general it is believed that strontium ranelate is capable of affecting a rebalance in bone turnover in favour of bone formation by 1 increasing osteoblast differentiation from progenitors osteoblast activity and survival as well as regulating osteoblast induced osteoclastogenesis and 2 decreasing osteoclast differentiation and activity as well as increasing osteoclast apoptosis A31541 It has also been shown that strontium ranelate is capable of improving and strengthening various components of overall bone tissue quality like bone mineral density and bone microarchitecture A31541 A31542 A31553",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00254",
                        "description": "The serum concentration of Doxycycline can be decreased when it is combined with Strontium ranelate"
                    },
                    {
                        "drugbank-id": "DB00256",
                        "description": "The serum concentration of Lymecycline can be decreased when it is combined with Strontium ranelate"
                    },
                    {
                        "drugbank-id": "DB00453",
                        "description": "The serum concentration of Clomocycline can be decreased when it is combined with Strontium ranelate"
                    },
                    {
                        "drugbank-id": "DB00595",
                        "description": "The serum concentration of Oxytetracycline can be decreased when it is combined with Strontium ranelate"
                    },
                    {
                        "drugbank-id": "DB00618",
                        "description": "The serum concentration of Demeclocycline can be decreased when it is combined with Strontium ranelate"
                    },
                    {
                        "drugbank-id": "DB00759",
                        "description": "The serum concentration of Tetracycline can be decreased when it is combined with Strontium ranelate"
                    },
                    {
                        "drugbank-id": "DB00931",
                        "description": "The serum concentration of Metacycline can be decreased when it is combined with Strontium ranelate"
                    },
                    {
                        "drugbank-id": "DB01017",
                        "description": "The serum concentration of Minocycline can be decreased when it is combined with Strontium ranelate"
                    },
                    {
                        "drugbank-id": "DB12035",
                        "description": "The serum concentration of Sarecycline can be decreased when it is combined with Strontium ranelate"
                    },
                    {
                        "drugbank-id": "DB12455",
                        "description": "The serum concentration of Omadacycline can be decreased when it is combined with Strontium ranelate"
                    },
                    {
                        "drugbank-id": "DB13264",
                        "description": "The serum concentration of Penimepicycline can be decreased when it is combined with Strontium ranelate"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Moxifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Enoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Pefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Trovafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Nalidixic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Rosoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Cinoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Lomefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Levofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Temafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Technetium Tc 99m ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Garenoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Nemonoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Flumequine resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11404",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Enrofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Orbifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Sarafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Difloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Pazufloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Prulifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Oxolinic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Rufloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "Strontium ranelate can cause a decrease in the absorption of Pipemidic acid resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00258",
                        "description": "The serum concentration of Strontium ranelate can be decreased when it is combined with Calcium acetate"
                    },
                    {
                        "drugbank-id": "DB00326",
                        "description": "The serum concentration of Strontium ranelate can be decreased when it is combined with Calcium glucoheptonate"
                    },
                    {
                        "drugbank-id": "DB01164",
                        "description": "The serum concentration of Strontium ranelate can be decreased when it is combined with Calcium chloride"
                    },
                    {
                        "drugbank-id": "DB01373",
                        "description": "The serum concentration of Strontium ranelate can be decreased when it is combined with Calcium"
                    },
                    {
                        "drugbank-id": "DB06724",
                        "description": "The serum concentration of Strontium ranelate can be decreased when it is combined with Calcium carbonate"
                    },
                    {
                        "drugbank-id": "DB11093",
                        "description": "The serum concentration of Strontium ranelate can be decreased when it is combined with Calcium citrate"
                    },
                    {
                        "drugbank-id": "DB11126",
                        "description": "The serum concentration of Strontium ranelate can be decreased when it is combined with Calcium gluconate"
                    },
                    {
                        "drugbank-id": "DB11348",
                        "description": "The serum concentration of Strontium ranelate can be decreased when it is combined with Calcium Phosphate"
                    },
                    {
                        "drugbank-id": "DB13231",
                        "description": "The serum concentration of Strontium ranelate can be decreased when it is combined with Calcium lactate"
                    },
                    {
                        "drugbank-id": "DB13365",
                        "description": "The serum concentration of Strontium ranelate can be decreased when it is combined with Calcium lactate gluconate"
                    },
                    {
                        "drugbank-id": "DB13590",
                        "description": "The serum concentration of Strontium ranelate can be decreased when it is combined with Calcium pangamate"
                    },
                    {
                        "drugbank-id": "DB14684",
                        "description": "The serum concentration of Strontium ranelate can be decreased when it is combined with Calcium polycarbophil"
                    },
                    {
                        "drugbank-id": "DB06723",
                        "description": "The serum concentration of Strontium ranelate can be decreased when it is combined with Aluminum hydroxide"
                    },
                    {
                        "drugbank-id": "DB09104",
                        "description": "The serum concentration of Strontium ranelate can be decreased when it is combined with Magnesium hydroxide"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}